Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience.

Paul J ScheelKatherine GiulianoCrystal TichnellCynthia JamesBrittney MurrayHarikrishna TandriDebra CarterTracey FehrPriya UmapathiJoban VaishnavSabra C LewseySteven HsuHugh CalkinsKavita SharmaChun Woo ChoiNisha A GilotraAhmet Kilic

Published in: ESC heart failure (2021)

Heart transplantation is a curative treatment for ARVC, but due to frequent ventricular arrhythmias and RV predominant pathology, patients require unique considerations in regard to timing of evaluation, haemodynamic support options, and wait listing qualification.

Keyphrases

end stage renal disease
heart failure
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
mycobacterium tuberculosis
left ventricular
atrial fibrillation
combination therapy
catheter ablation